Iron Metabolism in Normal and Pathological Pregnancies and Fetal Consequences

Charles Mégier1, Katell Peoc'h2, Vincent Puy3,4

  • 1Assistance Publique-Hôpitaux de Paris, Service de Gynécologie-Obstétrique, Hôpital Bicêtre, Université Paris Saclay, 94270 Le Kremlin-Bicetre, France.

Metabolites
|February 25, 2022
PubMed

Insights

This review updates knowledge on iron and heme metabolism in pregnancy. It details placental iron transport in normal and pathological pregnancies, including iron deficiency and hemoglobin diseases, impacting neonatal development.

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Biochemistry

Background:

  • Iron is vital for energy, DNA synthesis, and oxygen delivery via hemoglobin.
  • Placental iron metabolism is crucial for fetal development.
  • Iron deficiency and overload negatively impact maternal and neonatal health.

Purpose of the Study:

  • To review current knowledge on iron and heme metabolism in normal and pathological pregnancies.
  • To describe molecular actors in human placental iron metabolism.
  • To discuss the impact of iron deficiency and hemoglobin diseases on placental function.

Main Methods:

  • Literature review of iron and heme metabolism in pregnancy.
  • Analysis of molecular mechanisms in placental iron transport.
  • Synthesis of data on pathological pregnancies and their effect on iron metabolism.

Main Results:

  • Detailed description of molecular players in placental iron metabolism.
  • Elucidation of how iron deficiency and hemoglobinopathies affect placental iron handling.
  • Overview of iron metabolism alterations in common pathological pregnancies.

Conclusions:

  • Iron metabolism is critical during pregnancy, with the placenta playing a central role.
  • Both iron deficiency and overload pose risks to pregnancy outcomes and neonatal development.
  • Understanding these pathways is essential for managing pregnancy complications related to iron.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.0K
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
1.6K
The Periodic Table and Organismal Elements00:57

The Periodic Table and Organismal Elements

Overview
189.9K
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.8K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
292
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
1.3K